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India contributes to one-fifth of global live births and more than a quarter of neonatal deaths [1]. The problem of neonatal sepsis is enormous in the country. Hospital-based studies have 
revealed an incidence of 30/1000 live births, while community-
based studies indicate an incidence of 2.7–17% of all live births. 
About one-fifth of neonates are being diagnosed with sepsis 
disease in the hospital; the figure rises up to 50% for those with 
culture-proven sepsis. Their hospitalization period gets extended, 
the patients need additional resources. Such patients are also at 
a high risk of major neurodevelopmental disabilities at a later 
age [2,3].
Neonatal sepsis is a systemic infection occurring in infants 
at ≤28 days of life and is an important cause of morbidity and 
mortality of newborns [4]. In 2010 worldwide, 7.6 million 
children <5 years old died, predominantly due to infectious 
causes including sepsis, neonatal deaths (in the first 28 days 
of life) accounted for 40% of the total lives lost [5]. Despite 
major advances in neonatal care and increasing research, in 
developed countries, four of every 10 infants with sepsis die 
or experience major disability including significant permanent 
neurodevelopmental impairment [6]. Prematurely born neonates 
experience the highest incidence and mortality of sepsis among all 
age groups. Bacterial sepsis is a common cause of non-immune 
thrombocytopenia in neonatal intensive care unit (NICU) [7]. The 
main underlying pathology is increased destruction or decreased 
production of platelets. Several mechanisms are accountable for 
sepsis-induced thrombocytopenia, and it consists of accelerated 
platelet destruction, endothelial damage, and removal by the 
reticuloendothelial system, consumption from disseminated 
intravascular coagulation (DIC), binding of platelets to the 
bacterial products by platelet aggregation, and diminished 
production. Thrombocytopenia is reflected as the major sign of 
neonatal septicemia [8].
Thrombocytopenia is found in approximately 20–35% of 
babies who present to the NICU, whereas it is observed in 70% 
of very low birth weight (VLBW) babies with a higher rate 
of accompanying bleeding problems. A platelet count below 
150,000/mm3 is defined as thrombocytopenia and values below 
50,000/mm3 are defined as severe thrombocytopenia. Degrees of 
thrombocytopenia can be further subdivided into mild (platelet 
count 100,000–150,000/mm3), moderate (50,000–99,000/mm3), 
and severe (<50,000/mm3). Thrombocytopenia occurring in the 
first 3 days of life is classified as early-onset thrombocytopenia, 
and thrombocytopenia occurring after the 4th day is classified 
as late-onset thrombocytopenia. The most common causes of 
early-onset thrombocytopenia include maternal preeclampsia, 
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pregnancy-induced hypertension or diabetes, intrauterine 
growth retardation, perinatal infections, perinatal asphyxia, and 
transplacental transmission of maternal allo-/auto-antibodies. 
Late-onset thrombocytopenia is most commonly caused by 
postnatal infection and necrotizing enterocolitis [9].
Severe neonatal thrombocytopenia (platelet count 
<50,000/mL) is associated with bleeding and, potentially, 
significant morbidity, although there is a poor correlation 
between platelet count and incidence of bleeding. As a result, it is 
important to identify at-risk infants, and if needed, initiate therapy 
to prevent associated complications. Neonatal sepsis continues to 
remain a leading cause of morbidity and mortality worldwide. 
Neonatal sepsis is divided into two groups based on the age of 
presentation: Early-onset sepsis (EOS) at 72 h or before 7 days 
of life and late-onset sepsis (LOS) is defined as sepsis occurring 
at or after 72 h or 7 days of life. In developing countries, sepsis 
is the most common cause of mortality responsible for 30–50% 
of total neonatal deaths each year [10]. Gram-negative organisms 
are more commonly reported from India [11].
Therefore, it is a known fact that the high incidence of 
mortality is due to thrombocytopenia and neonatal sepsis in 
NICUs. This study was conducted to find out the bacteriological, 
clinical profile and the prevalence of thrombocytopenia in culture-
positive neonatal sepsis.
METHODS
This was a retrospective observational study conducted at the 
Department of Pediatrics of a Rural Medical College and tertiary 
care center, Maharashtra, India. Data were collected from 
previous records of NICU over 4 months from September 2018 
to December 2018. Clinical and laboratory data were collected 
from records during admission, i.e., laboratory reports, notes/case 
papers of neonates. Permission from the Institutional Research 
and Ethical Committee was taken before commencement of the 
study.
In this study, neonates aged below 28 days with culture-
positive sepsis were only included. Babies who were extremely 
low birth weight (LBW) (<1000 g), aged >28 days, neonates 
having maternal history suggestive of placental insufficiency, 
neonates with family history of bleeding manifestations, and 
newborn’s mother with low platelets counts, were excluded from 
the study. The blood cultures of the neonates were collected for 
the information regarding isolated organism, demographic profile, 
type of sepsis (EOS/LOS), presentation (non-specific/systemic), 
and hematology. Septic screening was done according to hospital 
protocols, and it consists of complete blood cell, blood culture, 
C-reactive protein, and erythrocyte sedimentation rate.
Definitions used in this study were; (a) neonatal period was 
referring to age <28 days after birth. (b) Culture-proven sepsis – 
when an infant having clinical picture suggestive of septicemia, 
pneumonia, or meningitis along with isolation of pathogen from 
blood. (c) Normal platelets count referred to platelets count of 
>150,000/mm3. (d) Thrombocytopenia was defined as newborn 
infants having platelets counts below 150,000/mm3. Mild, 
moderate, and severe thrombocytopenia were defined as when 
platelet counts between 100,000 and 150,000/mm3, 50,000 and 
100,000/mm3, and <50,000/mm3. (e) Prevalence is the proportion 
of disease found to have been affecting a particular population.
The data were recorded and analyzed using the MS Excel 
2010. Association and correlation of qualitative data were tested 
by Chi-square test and “p<0.05” was considered statistically 
significant.
RESULTS
The study population was selected as per the inclusion criteria 
and a total of 54 newborns were included in the study. Of these 
54 newborns, 29 (53.70%) were male and 25 (46.30%) were 
female. Extramural neonates were 26 (48.14%) and intramural 
were 28 (51.86%). EOS was seen in 39 (72.22%) cases and those 
15 (27.78%) had LOS. Table 1 shows the birth weight, mode 
of delivery, and thrombocytopenia, in the patients. Among the 
patients, 8 (14.81%) children had VLBW and preterm delivery 
was seen in 19 (35.18%), whereas term 33 (61.11%) and post-
term neonates were 2 (3.7%).
The most common organism isolated in blood culture were 
Klebsiella pneumoniae in 21 (38.88%) cases, followed by 
Pseudomonas (15, 27.77%), Staphylococcus (9, 16.66%), and 
Escherichia coli (9, 16.66%). Thrombocytopenia was present 
in 49/54 patients (90.74%). As per the severity grading, severe 
thrombocytopenia was found in 21 (42.86%) neonates, moderate 
in 17 (34.69%), and mild in 11 (22.45%) neonates, respectively. 
As presented in Table 2, severe thrombocytopenia was found in 
7/21 (33.33%) patients with K. pneumoniae infection, followed 
by 6/21 (28.57%) with Pseudomonas spp., 5/21 (23.80%) with 
Staphylococcus aureus, and 3/21 (14.28%) neonates with E. coli 
infection (p=0.016).
According to organism isolated in blood culture, 
K. pneumoniae was the leading cause of death in 10/21 (47.61%) 
newborns followed by Pseudomonas spp. 4/15 (26.66%), E. coli 
1/9 (11.11%), and S. aureus sepsis in 1/9 (11.11%) neonates.
DISCUSSION
As per the study results, culture-positive sepsis was seen more 
common among male (53.70%) than the female (46.30%) 
neonates. This finding was similar to the previous study by 
Singh et al. and Raha et al., where 62.5% were male neonates 
and 37.5% were female. Even though recent developments in 
medical expertise have enhanced the survival of LBW infants, 
they remain at a high risk for sepsis [12]. In this study, 29 neonates 
Table 1: Birth weight, mode of delivery, and thrombocytopenia
Parameters N (%) Thrombocytopenia (%)
Normal 25 (46.29) 21 (84)
Low 29 (53.7) 28 (96.55)
Normal delivery 41 (75.92) 39 (95.12)
Cesarean section 13 (24.8) 10 (76.92)
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with sepsis had LBW of these 28 (96.55%) babies developed 
thrombocytopenia. One of the most common hematological 
manifestation during early sepsis is thrombocytopenia; thus, 
platelet count may act as an early marker for the diagnosis of 
septicemia [13].
The results of the present study showed thrombocytopenia in 
49/54 (90.74%) neonates. The prevalence of thrombocytopenia 
among neonatal sepsis patients was significant in various 
previous studies across the globe. As per Singh et al., percentage 
of thrombocytopenia was 95.2%, while the study by Abdulla 
et al. showed 42.8% incidence of thrombocytopenia in neonatal 
sepsis [12]. A study by Sindhura and Reddy found that the number 
needed to treat (<150,000/mm3) can be used to screen neonate 
with sepsis with sensitivity of 82.6% [13].
In our study, as per the severity grading, severe 
thrombocytopenia was found in 21 (42.86%) neonates, 
moderate in 17 (34.69%), and mild in 11 (22.45%) neonates. 
According to the study by Karne et al. in proven sepsis, severe 
thrombocytopenia was present in 57.5% of patients, while mild 
and moderate thrombocytopenia was seen in 22.5% and 20.0% 
of cases, respectively [14]. This indicates that the low platelets in 
newborns have important correlation with sepsis and admission 
in the NICU. The severity grading of thrombocytopenia also 
represents that it was associated with culture-positive sepsis. 
The majority of the study cohort had a positive blood culture for 
K. pneumoniae. As per Shukla and Rawat, high culture positivity 
rate was seen in LBW neonates [15].
As per blood culture test, K. pneumoniae was the 
most common organism, followed by Pseudomonas (15), 
Staphylococcus (9), and E. coli (9). Similar results were found 
by Singh et al. where K. pneumoniae was found in 44.8% 
(47/105) newborns, followed by Pseudomonas spp. 24.8% 
(26/105), E. coli 13.3% (14/105), S. aureus 10.5% (11/105), 
and Candida spp. 1.9% (2/105) [16]. Verma and Sadawarte 
found that S. aureus (58.62%) was the most common followed 
by Klebsiella (16.09%) coagulase-negative Staphylococcus 
(6.89%) [17]. Karne et al. found that Pseudomonas aeruginosa 
was the most common organism causing neonatal sepsis 
accompanying severe thrombocytopenia (64.7%) than the mild 
or moderate thrombocytopenia [18]. In a study by Torkman 
et al., Enterobacter was the most common organism causing 
neonatal sepsis with thrombocytopenia [19]. Khassawneh 
et al., from Jordan, also reported Gram-negative organisms 
as the most common cause of neonatal sepsis [20]. S. aureus 
colonizes skin, nasopharynx, and gastrointestinal tract and 
spreads through hands of health care workers. This suggests 
a prerequisite for better adherence to hygiene practices and 
isolation of health care workers.
Platelet indices in neonates with EOS and LOS, 
thrombocytopenia was significantly higher in LOS which is 
supported from a study by Kudawla et al. The same study also 
concluded that decreased platelet count was seen more frequently 
in LOS group [18]. Most commonly, it is the Gram-negative 
organisms responsible for neonatal sepsis.
The pathogenesis of thrombocytopenia in neonatal sepsis is 
not clear. Thrombocytopenia may just be a marker of severity of 
sepsis, as Gram-negative sepsis is more severe than Gram-positive 
ones and sepsis can cause DIC. A direct pathophysiological 
mechanism of endotoxins produced by Gram-negative bacteria 
in neonatal sepsis could also contribute. Both bacterial groups 
show a great inhomogeneity, with a different pathogenicity for 
each separate bacterial species [21]. Theoretically, the observed 
differences in this study could be completely attributed to the 
individual pathogenic effect of coagulase-negative staphylococci 
and E. coli, as those bacteria were the most abundant in our 
groups.
This study has shown the trend toward a higher occurrence 
of pulmonary hemorrhage and mortality in septic neonates with 
severe and very severe thrombocytopenia, compared to neonates 
with platelets >50,000/mm3. Mortality observed in our study was 
16 (32.65%) which is similar to the previous study by Kumar et al. 
where the mortality was 25%. Thrombocytopenia is also known 
to be of prognostic value [21]. Thrombocytopenia was found to 
be consistently associated with poor prognosis, confirming the 
finding of other studies [12-16].
The study results and interpretations do have few restrictions 
including that it was a retrospective study in nature and has 
possibility of being bias. This study was not powered to evaluate 
the differences in bleeding events and did not take into full 
account the time relation between the bleeding events and actual 
occurrence of thrombocytopenia, or other potential factors 
influencing the risk of bleeding such as hemodynamic instability.
CONCLUSION
Thrombocytopenia was common among sepsis due to 
K. pneumonia, Pseudomonas, Staphylococcus, and E. coli 
organisms. Severe thrombocytopenia shows an increased 
association with major hemorrhages and mortality. Ideally, a 
large sample-based, prospective multicenter study would be able 
to clarify various factors associated with and mortality in neonatal 
sepsis.
Table 2: Severity of thrombocytopenia as per organism found in blood culture
Organisms found Normal Mild Moderate Severe Total Mortality
Klebsiella pneumoniae 0 5 9 7 21 10
Pseudomonas spp. 2 2 5 6 15 4
Staphylococcus aureus 1 1 2 5 9 1
Escherichia coli 2 3 1 3 9 1
Total 5 11 17 21 54 16
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